US Stock MarketDetailed Quotes

GPCR Structure Therapeutics

Watchlist
  • 27.900
  • -2.070-6.91%
Close Dec 20 16:00 ET
  • 27.890
  • -0.010-0.04%
Post 20:01 ET
1.60BMarket Cap-14.45P/E (TTM)

Structure Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
345.56%915.29M
312.81%927.12M
81.20%436.45M
414.44%467.32M
414.44%467.32M
99.92%205.42M
--224.59M
--240.86M
-15.34%90.84M
-15.34%90.84M
-Cash and cash equivalents
239.94%172.13M
840.18%381.63M
-22.66%97.83M
397.46%129.79M
397.46%129.79M
80.25%50.64M
--40.59M
--126.49M
-75.22%26.09M
-75.22%26.09M
-Short-term investments
380.11%743.16M
196.47%545.49M
196.07%338.62M
421.28%337.53M
421.28%337.53M
107.33%154.79M
--184M
--114.37M
3,134.27%64.75M
3,134.27%64.75M
Other current assets
84.45%8.37M
188.91%10.5M
143.93%12.91M
179.58%6.29M
179.58%6.29M
124.95%4.54M
--3.64M
--5.29M
15.70%2.25M
15.70%2.25M
Total current assets
339.92%923.65M
310.84%937.62M
82.55%449.36M
408.77%473.61M
408.77%473.61M
100.41%209.96M
--228.22M
--246.16M
-14.79%93.09M
-14.79%93.09M
Non current assets
Net PPE
27.77%7.74M
549.14%7.58M
586.39%7.82M
546.87%8.36M
546.87%8.36M
342.41%6.06M
--1.17M
--1.14M
-27.93%1.29M
-27.93%1.29M
-Gross PPE
37.30%9.11M
422.58%8.68M
457.38%8.68M
448.60%9.01M
448.60%9.01M
302.73%6.63M
--1.66M
--1.56M
-12.00%1.64M
-12.00%1.64M
-Accumulated depreciation
-138.29%-1.36M
-122.72%-1.1M
-106.68%-866K
-84.53%-644K
-84.53%-644K
-106.50%-572K
---493K
---419K
-384.72%-349K
-384.72%-349K
Other non current assets
420.57%1.82M
4,705.26%1.83M
-20.34%47K
-98.70%45K
-98.70%45K
-84.57%350K
--38K
--59K
3,019.82%3.46M
3,019.82%3.46M
Total non current assets
49.21%9.57M
680.10%9.41M
556.51%7.87M
76.81%8.41M
76.81%8.41M
76.17%6.41M
--1.21M
--1.2M
149.66%4.76M
149.66%4.76M
Total assets
331.31%933.22M
312.78%947.03M
84.85%457.23M
392.63%482.02M
392.63%482.02M
99.59%216.37M
--229.43M
--247.35M
-11.97%97.85M
-11.97%97.85M
Liabilities
Current liabilities
Payables
120.21%8.59M
-61.70%2.25M
35.37%6.84M
-17.55%5.1M
-17.55%5.1M
-33.35%3.9M
--5.88M
--5.05M
66.43%6.18M
66.43%6.18M
-accounts payable
154.50%8.45M
-61.24%2.21M
32.21%6.54M
-21.09%4.74M
-21.09%4.74M
-41.80%3.32M
--5.7M
--4.95M
72.47%6.01M
72.47%6.01M
-Total tax payable
-76.03%139K
-76.70%41K
185.58%297K
104.60%356K
104.60%356K
294.56%580K
--176K
--104K
-24.68%174K
-24.68%174K
Current accrued expenses
41.98%17.02M
116.67%14.78M
190.86%13.11M
359.05%13.88M
359.05%13.88M
264.19%11.99M
--6.82M
--4.51M
14.03%3.02M
14.03%3.02M
Current debt and capital lease obligation
109.55%1.71M
2,131.51%1.63M
852.38%1.6M
453.85%1.44M
453.85%1.44M
147.58%817K
--73K
--168K
-25.50%260K
-25.50%260K
-Current capital lease obligation
109.55%1.71M
2,131.51%1.63M
852.38%1.6M
453.85%1.44M
453.85%1.44M
147.58%817K
--73K
--168K
-25.50%260K
-25.50%260K
Current liabilities
66.41%33.43M
50.93%22.66M
114.38%23.59M
90.16%24.74M
90.16%24.74M
64.29%20.09M
--15.01M
--11M
50.27%13.01M
50.27%13.01M
Non current liabilities
Long term debt and capital lease obligation
-11.90%2.67M
--3.05M
--3.53M
--4.01M
--4.01M
--3.03M
----
----
--0
--0
-Long term capital lease obligation
-11.90%2.67M
--3.05M
--3.53M
--4.01M
--4.01M
--3.03M
----
----
--0
--0
Preferred securities outside stock equity
----
----
----
--0
--0
--0
--0
--0
19.77%199.98M
19.77%199.98M
Other non current liabilities
9.96%309K
29,200.00%293K
--296K
--298K
--298K
144.35%281K
--1K
----
----
----
Total non current liabilities
-10.05%2.98M
333,700.00%3.34M
--3.82M
-97.84%4.31M
-97.84%4.31M
-98.34%3.32M
--1K
--0
19.58%199.98M
19.58%199.98M
Total liabilities
55.58%36.42M
73.15%26M
149.11%27.41M
-86.36%29.05M
-86.36%29.05M
-88.98%23.41M
--15.01M
--11M
21.09%212.99M
21.09%212.99M
Shareholders'equity
Share capital
54.55%17K
70.00%17K
27.27%14K
1,300.00%14K
1,300.00%14K
1,000.00%11K
--10K
--11K
0.00%1K
0.00%1K
-common stock
54.55%17K
70.00%17K
27.27%14K
1,300.00%14K
1,300.00%14K
1,000.00%11K
--10K
--11K
0.00%1K
0.00%1K
-Preferred stock
--0
--0
--0
--0
--0
----
----
----
--0
--0
Retained earnings
-60.72%-292.62M
-63.48%-258.64M
-72.40%-232.61M
-76.63%-206.57M
-76.63%-206.57M
-73.27%-182.07M
---158.21M
---134.93M
-80.66%-116.95M
-80.66%-116.95M
Paid-in capital
216.14%1.19B
216.39%1.18B
78.51%662.5M
34,205.21%659M
34,205.21%659M
28,816.18%375.33M
--373M
--371.12M
--1.92M
--1.92M
Gains losses not affecting retained earnings
1,015.81%2.84M
-24.87%-487K
-161.22%-90K
573.64%521K
573.64%521K
-129.63%-310K
---390K
--147K
---110K
---110K
Total stockholders'equity
364.75%896.8M
329.56%921.03M
81.86%429.82M
493.40%452.97M
493.40%452.97M
285.70%192.96M
--214.41M
--236.35M
-77.86%-115.14M
-77.86%-115.14M
Total equity
364.75%896.8M
329.56%921.03M
81.86%429.82M
493.40%452.97M
493.40%452.97M
285.70%192.96M
--214.41M
--236.35M
-77.86%-115.14M
-77.86%-115.14M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 345.56%915.29M312.81%927.12M81.20%436.45M414.44%467.32M414.44%467.32M99.92%205.42M--224.59M--240.86M-15.34%90.84M-15.34%90.84M
-Cash and cash equivalents 239.94%172.13M840.18%381.63M-22.66%97.83M397.46%129.79M397.46%129.79M80.25%50.64M--40.59M--126.49M-75.22%26.09M-75.22%26.09M
-Short-term investments 380.11%743.16M196.47%545.49M196.07%338.62M421.28%337.53M421.28%337.53M107.33%154.79M--184M--114.37M3,134.27%64.75M3,134.27%64.75M
Other current assets 84.45%8.37M188.91%10.5M143.93%12.91M179.58%6.29M179.58%6.29M124.95%4.54M--3.64M--5.29M15.70%2.25M15.70%2.25M
Total current assets 339.92%923.65M310.84%937.62M82.55%449.36M408.77%473.61M408.77%473.61M100.41%209.96M--228.22M--246.16M-14.79%93.09M-14.79%93.09M
Non current assets
Net PPE 27.77%7.74M549.14%7.58M586.39%7.82M546.87%8.36M546.87%8.36M342.41%6.06M--1.17M--1.14M-27.93%1.29M-27.93%1.29M
-Gross PPE 37.30%9.11M422.58%8.68M457.38%8.68M448.60%9.01M448.60%9.01M302.73%6.63M--1.66M--1.56M-12.00%1.64M-12.00%1.64M
-Accumulated depreciation -138.29%-1.36M-122.72%-1.1M-106.68%-866K-84.53%-644K-84.53%-644K-106.50%-572K---493K---419K-384.72%-349K-384.72%-349K
Other non current assets 420.57%1.82M4,705.26%1.83M-20.34%47K-98.70%45K-98.70%45K-84.57%350K--38K--59K3,019.82%3.46M3,019.82%3.46M
Total non current assets 49.21%9.57M680.10%9.41M556.51%7.87M76.81%8.41M76.81%8.41M76.17%6.41M--1.21M--1.2M149.66%4.76M149.66%4.76M
Total assets 331.31%933.22M312.78%947.03M84.85%457.23M392.63%482.02M392.63%482.02M99.59%216.37M--229.43M--247.35M-11.97%97.85M-11.97%97.85M
Liabilities
Current liabilities
Payables 120.21%8.59M-61.70%2.25M35.37%6.84M-17.55%5.1M-17.55%5.1M-33.35%3.9M--5.88M--5.05M66.43%6.18M66.43%6.18M
-accounts payable 154.50%8.45M-61.24%2.21M32.21%6.54M-21.09%4.74M-21.09%4.74M-41.80%3.32M--5.7M--4.95M72.47%6.01M72.47%6.01M
-Total tax payable -76.03%139K-76.70%41K185.58%297K104.60%356K104.60%356K294.56%580K--176K--104K-24.68%174K-24.68%174K
Current accrued expenses 41.98%17.02M116.67%14.78M190.86%13.11M359.05%13.88M359.05%13.88M264.19%11.99M--6.82M--4.51M14.03%3.02M14.03%3.02M
Current debt and capital lease obligation 109.55%1.71M2,131.51%1.63M852.38%1.6M453.85%1.44M453.85%1.44M147.58%817K--73K--168K-25.50%260K-25.50%260K
-Current capital lease obligation 109.55%1.71M2,131.51%1.63M852.38%1.6M453.85%1.44M453.85%1.44M147.58%817K--73K--168K-25.50%260K-25.50%260K
Current liabilities 66.41%33.43M50.93%22.66M114.38%23.59M90.16%24.74M90.16%24.74M64.29%20.09M--15.01M--11M50.27%13.01M50.27%13.01M
Non current liabilities
Long term debt and capital lease obligation -11.90%2.67M--3.05M--3.53M--4.01M--4.01M--3.03M----------0--0
-Long term capital lease obligation -11.90%2.67M--3.05M--3.53M--4.01M--4.01M--3.03M----------0--0
Preferred securities outside stock equity --------------0--0--0--0--019.77%199.98M19.77%199.98M
Other non current liabilities 9.96%309K29,200.00%293K--296K--298K--298K144.35%281K--1K------------
Total non current liabilities -10.05%2.98M333,700.00%3.34M--3.82M-97.84%4.31M-97.84%4.31M-98.34%3.32M--1K--019.58%199.98M19.58%199.98M
Total liabilities 55.58%36.42M73.15%26M149.11%27.41M-86.36%29.05M-86.36%29.05M-88.98%23.41M--15.01M--11M21.09%212.99M21.09%212.99M
Shareholders'equity
Share capital 54.55%17K70.00%17K27.27%14K1,300.00%14K1,300.00%14K1,000.00%11K--10K--11K0.00%1K0.00%1K
-common stock 54.55%17K70.00%17K27.27%14K1,300.00%14K1,300.00%14K1,000.00%11K--10K--11K0.00%1K0.00%1K
-Preferred stock --0--0--0--0--0--------------0--0
Retained earnings -60.72%-292.62M-63.48%-258.64M-72.40%-232.61M-76.63%-206.57M-76.63%-206.57M-73.27%-182.07M---158.21M---134.93M-80.66%-116.95M-80.66%-116.95M
Paid-in capital 216.14%1.19B216.39%1.18B78.51%662.5M34,205.21%659M34,205.21%659M28,816.18%375.33M--373M--371.12M--1.92M--1.92M
Gains losses not affecting retained earnings 1,015.81%2.84M-24.87%-487K-161.22%-90K573.64%521K573.64%521K-129.63%-310K---390K--147K---110K---110K
Total stockholders'equity 364.75%896.8M329.56%921.03M81.86%429.82M493.40%452.97M493.40%452.97M285.70%192.96M--214.41M--236.35M-77.86%-115.14M-77.86%-115.14M
Total equity 364.75%896.8M329.56%921.03M81.86%429.82M493.40%452.97M493.40%452.97M285.70%192.96M--214.41M--236.35M-77.86%-115.14M-77.86%-115.14M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Weight Loss Drugs
Weight Loss Drugs
Intraday-4.61%